These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2720893)

  • 1. Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study.
    Marshall ME; Butler K; Cantrell J; Wiseman C; Mendelsohn L
    Cancer Chemother Pharmacol; 1989; 24(1):65-6. PubMed ID: 2720893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of advanced malignant melanoma with coumarin and cimetidine.
    Nolte H; Pedersen L; Mouridsen HT
    Anticancer Res; 1987; 7(3 Pt B):449-50. PubMed ID: 3631904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine and coumarin therapy of renal cell carcinoma. A pilot study.
    Kokron O; Maca S; Gasser G; Schmidt PR
    Oncology; 1991; 48(2):102-6. PubMed ID: 1997930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment of advanced malignant melanoma with coumarin and cimetidine. A phase II study.
    Pedersen L; Rose C; Langvad E
    Cancer Immunol Immunother; 1987; 24(2):178-9. PubMed ID: 3829053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hormone-refractory stage D carcinoma of prostate with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.
    Marshall ME; Butler K; Hermansen D
    Prostate; 1990; 17(2):95-9. PubMed ID: 2399194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies.
    Marshall ME; Butler K; Fried A
    Mol Biother; 1991 Sep; 3(3):170-8. PubMed ID: 1768368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.
    Marshall ME; Mendelsohn L; Butler K; Riley L; Cantrell J; Wiseman C; Taylor R; Macdonald JS
    J Clin Oncol; 1987 Jun; 5(6):862-6. PubMed ID: 3585442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma.
    Dexeus FH; Logothetis CJ; Sella A; Fitz K; Amato R; Reuben JM; Dozier N
    J Clin Oncol; 1990 Feb; 8(2):325-9. PubMed ID: 2137163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of coumarin (1,2-benzopyrone) and cimetidine on peripheral blood lymphocytes, natural killer cells, and monocytes in patients with advanced malignancies.
    Marshall ME; Riley LK; Rhoades J; Eichhorn T; Jennings CD; Cibull M; Thompson J
    J Biol Response Mod; 1989 Feb; 8(1):62-9. PubMed ID: 2921610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coumarin plus cimetidine: yet another angle for therapy of renal cell carcinoma.
    Kirkwood JM; Ernstoff MS
    J Clin Oncol; 1987 Jun; 5(6):836-7. PubMed ID: 3585440
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of coumarin and cimetidine in advanced renal cell carcinoma.
    Herrmann R; Manegold C; Maurer B; Hennig FW; Matthiessen W
    Ann Oncol; 1990 Nov; 1(6):445-6. PubMed ID: 2083188
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of recombinant interferon alpha 2 and cimetidine in patients with advanced malignant melanoma.
    Mughal TI; Robinson WA; Thomas MR; Spiegel R
    J Cancer Res Clin Oncol; 1988; 114(1):108-9. PubMed ID: 3350837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cimetidine and coumarin therapy of melanoma.
    Thornes RD; Lynch G; Sheehan MV
    Lancet; 1982 Aug; 2(8293):328. PubMed ID: 6124738
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma.
    Morton RF; Creagan ET; Cullinan SA; Mailliard JA; Ebbert L; Veeder MH; Chang M
    J Clin Oncol; 1987 Jul; 5(7):1078-82. PubMed ID: 3598611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous interleukin-2 and interferon-alpha plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study.
    Schmidt H; Geertsen PF; Fode K; Rytter C; Bastholt L; von der Maase H
    Melanoma Res; 2000 Feb; 10(1):66-77. PubMed ID: 10711642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of non-small cell lung cancer with coumarin and cimetidine.
    Marshall ME; Mendelsohn L; Butler K; Cantrell J; Harvey J; Macdonald J
    Cancer Treat Rep; 1987 Jan; 71(1):91-2. PubMed ID: 3024830
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin-2 and high-dose cisplatin in patients with metastatic melanoma: a pilot study.
    Demchak PA; Mier JW; Robert NJ; O'Brien K; Gould JA; Atkins MB
    J Clin Oncol; 1991 Oct; 9(10):1821-30. PubMed ID: 1655988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
    Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY
    Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients.
    Creagan ET; Ahmann DL; Frytak S; Long HJ; Chang MN; Itri LM
    Cancer Treat Rep; 1986 May; 70(5):619-24. PubMed ID: 3518925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.
    Sznol M; Clark JW; Smith JW; Steis RG; Urba WJ; Rubinstein LV; VanderMolen LA; Janik J; Sharfman WH; Fenton RG
    J Natl Cancer Inst; 1992 Jun; 84(12):929-37. PubMed ID: 1629914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.